Investigational Nasal Spray Modestly Reduces OSA Severity
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
Tag: OSA
All
Latest
Investigational Nasal Spray Modestly Reduces OSA Severity
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
Read More
Samsung Galaxy Watch’s Sleep Apnea Feature Granted FDA De Novo Status
This over-the-counter feature, which detects signs of sleep apnea using a compatible Samsung Galaxy Watch and phone.
Read More
CPAP Cuts OSA Patients’ Cardiovascular Death Risk by 36%
A small patient trial also suggests CPAP may be more effective than a weight-loss drug in tackling clogged arteries.
Read More
Investigational OSA Approach Sidelines CPAP
New research challenges traditional therapy models, offering a novel approach to treating obstructive sleep apnea. According to the study’s investigators, most OSA patients were treated without the use of CPAP.
Read More
Philips CEO Steps Down Amid Recall
Philips CEO Frans van Houten has stepped down from the role with Roy Jakobs set to replace him as CEO effective October 15, 2022, according to a press announcement from Royal Philips.
Read More
Apnimed’s Second Core Sleep Apnea Drug Candidate, AD504, Lowers AHI
Apnimed shared data from a proof-of-concept study exploring two potential oral therapeutic candidates for the treatment of patients with obstructive sleep apnea.
Read MoreFisher & Paykel Launches Evora Full Mask
Fisher & Paykel Healthcare launches F&P Evora Full, a new full face CPAP mask, in the United States. Evora Full will be available for purchase by durable medical equipment companies starting May 9.
Read More